Case Report on Antiphospholipid Syndrome and Alloimmunity Pregnancy Outcome in Women

Authors

  • Ruthi Lalhminghlui
  • Sonali Kolhekar
  • Achita Sawarkar

Keywords:

Aspirin, Heparin, Immunotherapy, Routine abortion, Syndrome of antiphospholipid

Abstract

Background: Pregnancy outcomes are poor for patients with antiphospholipid syndrome and alloimmunity. Although there is no agreement on the optimum course of treatment for these illnesses, there are numerous diagnostic and therapeutic alternatives available. We describe the clinical course and therapy of a woman who joined our programme ten years ago and has been monitored ever since with a history of two miscarriages. Her unfractionated heparin, aspirin, prednisone, and lymphocyte therapy were used before conception and immunizations of antiphospholipid syndrome and alloimmune failure were identified. In the ensuing two pregnancies, she gave birth to two premature kids. Both children are currently healthy and enrolled in school. Despite having completed a similar but postconceptional therapy plan, the fifth pregnancy was unsuccessful. We focus on the pathogenic mechanisms and treatment facets of these illnesses as we analyse this case in which heparin, aspirin, antiphospholipid syndrome, routine abortion, and immunotherapy are used.

Published

2024-05-17

How to Cite

Lalhminghlui, R. ., Kolhekar, S. ., & Sawarkar, A. . (2024). Case Report on Antiphospholipid Syndrome and Alloimmunity Pregnancy Outcome in Women. International Journal of Studies in Midwifery and Women’s Health, 5(2), 15–19. Retrieved from https://matjournals.net/nursing/index.php/IJSMWH/article/view/98

Issue

Section

Articles